デジタルパソロジーの世界市場:産業分析・機会分析

◆英語タイトル:Digital Pathology Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025
◆商品コード:FMI609136
◆発行会社(調査会社):Future Market Insights
◆発行日:2016年3月15日
◆ページ数:258
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。Future Market Insights社の概要及び新刊レポートはこちらでご確認いただけます。



※本調査レポートでは、デジタルパソロジーの世界市場について調査・分析し、市場概観、デジタルパソロジーの世界市場規模、市場規模予測、地域別分析(アメリカ、ヨーロッパ、アジア等)、セグメント別市場分析、競争状況、デジタルパソロジー市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
【レポートの概要】

Future Market Insights (FMI) offers a 10-year forecast of the global digital pathology market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 11.4% during the forecast period. This study provides insights regarding the market dynamics and trends in all seven regions that are expected to influence the current market environment and future status of the global digital pathology market over the forecast period.
Report Description

This report examines the global digital pathology market for the period 2015–2025, with the primary objective being to offer key insights on developments in the global digital pathology market, that are significantly helping to provide more integrated and digitised platform for the healthcare service providers by making the process of sharing slides across the health care sector mush easier.

The global digital pathology market report begins by defining digital pathology systems and the various components such as scanners, software and services that make up the whole package. It also lists the various end users opting for digital pathology systems, followed by an overview section, along with its parent market. Overview section includes FMI’s analysis of key trends, drivers, restraints and opportunities estimated to influence growth of the global digital pathology market over the forecast period. Impact analysis of key growth drivers and restraints based on weighted average model has been analysed to better equip customers and readers with region-specific trends, drivers, restraints and market insights.

Major factors driving growth of the global digital pathology market include increasing spending on cancer diagnostics and monitoring, increasing spending on healthcare IT and collaborative approach between pathologists and cloud service providers to facilitate faster decision making. Furthermore, increasing demand for image analysis software and personalised medicine has triggered growth of global digital pathology market. Research indicates that there is growing need for integrated modules of digital pathology, which enables better interoperability reliable outcome to pathologists. Secondly, there is growing need for automation in diagnostic procedures, starting from sample collection to final diagnosis, and this is estimated to further fuel demand for digital pathology systems for application in research laboratories and diagnostic laboratories. However, factors such as high capital cost for implementing digital pathology systems and stringent regulatory guidance for the use of digital pathology systems in primary diagnosis are factors hampering growth of the digital pathology market.

The global digital pathology market is segmented based on the basis of product type into hardware (scanners), software and services. Scanners segment is further sub-segmented into fluorescent scanners and bright field scanners. Scanners segment is further sub-segment into fluorescent digital pathology scanners and bright field digital pathology scanners. The software segment is further sub-segmented into image analysis and digital pathology information systems. On the basis of deployment mode, the image analysis and digital pathology information systems sub-segments are categorized as on-premise delivery and cloud based delivery solutions. The services segment is further sub-segmented into installation & integration services, consulting services and maintenance services. On the basis of end user, the market is segmented into hospitals, diagnostic laboratories and research centres. A detailed analysis of all the categories of end users has been provided in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

The report analyses the market based on digital pathology screening services such as haematology, chemical pathology, histopathology and medical microbiology. A thorough analysis, along with the market attractiveness index of each of these categories, has been provided in the report.

In the above sections – by product, end user, pathology screening services and region – we evaluate the present scenario and future growth prospects of the global digital pathology market for the period 2015 – 2025. We have considered 2014 as the base year and provided data for the forecast period, i.e. 2015-2025.

The next section of report highlights the digital pathology market by region. It provides the market outlook for 2015-2025 and sets the forecast within the context of the global digital pathology market. The study discusses key regional trends, drivers and restraints contributing to growth of digital pathology market, worldwide. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa.

To ascertain size of the global digital pathology (devices) market, we have considered the revenue generated from the sale of digital pathology software and scanners. The forecast presented here assesses total revenue generated across the digital pathology market, globally over the forecast period. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the digital pathology market is expected to develop in the future. Given the characteristics of the market, we have triangulated the outcome on the basis of supply-side and demand-side perspective, and downstream industry and economic envelope.

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse based on key parameters, such as Year-On-Year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities available in the market.

The global digital pathology market has been segmented in terms of products, pathology screening services, end users and regions, are analysed on the basis of their respective Basis Point Share (BPS) to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends in the global market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of digital pathology market.

To understand key growth segments in terms of growth, Future Market Insights developed the digital pathology market ‘Attractiveness Index’. The resulting index helps providers to identify real market opportunities and take informed decisions.

In the final section of the report, we offer the ‘Competitive Landscape’ section to provide report audiences with a dashboard view and to examine the key differentiators among competitor firms. Key categories of providers covered in the report are digital pathology scanners, software and service providers. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the digital pathology value chain. This section also includes market strategies and SWOT analysis of the key players in the market.

Detailed profiles of digital pathology companies included are in the scope of the report to evaluate their long-term and short-term strategies. Key players in the market include:

Perkin Elmer, Inc.,
MedImmune, LLC (AstraZeneca),
Sectra AB
Koninklijke Philips N.V
GE Healthcare
Inspirata Co.
Ventana Medical Systems, Inc.
Leica Biosystems
3D-Histech Ltd.
Hamamatsu Photonics, K.K.
Digipath Co.
ZEISS
Olympus Corporation
Yokogawa Electronic Corporation.

Key Segments Covered

By Product
Scanner
Bright Field Scanner
Fluorescence Scanner
Software
Image Analysis Platform
On-premises Delivery
Cloud-based Delivery
Digital Pathology Information Systems
On-premises Delivery
Cloud-based Delivery
Services
Installation and Integration
Maintenance Services
Consulting Services
By End Use
Hospital
500+ Beds
200–499 Beds
Less than 200 Beds
Diagnostic Laboratories
Private Laboratories
Public Laboratories
Research Centers
By Pathology Screening Services
Hematology
Chemical Pathology
Histopathology
Medical Microbiology

【レポートの目次】

Table Of Content

1. Digital Pathology Market – Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Digital Pathology Market Overview

4.1. Introduction

4.1.1. Digital Pathology Market Definition

4.1.2. Digital Pathology Market Taxonomy

4.2. Digital Pathology Parent Market Overview

4.3. Global Digital Pathology Market Forecast, 2015–2025

4.3.1. Digital Pathology Market Size (Value) Forecast

4.3.1.1. Y-o-Y Growth Projections

4.3.1.2. Absolute $ Opportunity

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunity

4.5. Pathology Market Trends

4.6. Regulatory Scenario

4.6.1. US

4.6.2. Canada

4.6.3. Europe

4.7. Primary (KOL) Outlooks

4.8. Attributes of cloud services

4.9. Industry life cycle and Competition Strategies

4.10. Consumer Adoption Process: Digital Pathology

4.10.1. North America and Europe

4.10.2. APAC and MEA

4.11. Pricing Analysis: Digital Pathology Systems

4.12. Commercial progress of digital pathology

4.12.1. Bottom Line of digital pathology installation

4.13. Global Digital Pathology Installed Base Scenario

5. Global Digital Pathology Market Analysis, By Product Type

5.1. Introduction

5.1.1. Global Digital Pathology Market Snapshot By Product Type

5.1.2. Y-o-Y Growth Comparison, By Product Type

5.1.3. Basis Point Share (BPS) Analysis, By Product Type

5.2. Digital Pathology Market Forecast By Product Type

5.2.1. Scanners

5.2.1.1. Whole Slide Imaging System

5.2.1.1.1. Bright Field Scanner

5.2.1.1.1.1. Absolute $ Opportunity

5.2.1.1.1.2. Market Value Forecast, By Region

5.2.1.1.2. Fluorescence Scanner

5.2.1.1.2.1. Absolute $ Opportunity

5.2.1.1.2.2. Market Value Forecast, By Region

5.2.2. Software

5.2.2.1. Image Analysis Platform

5.2.2.1.1. On-Premises Delivery

5.2.2.1.1.1. Absolute $ Opportunity

5.2.2.1.1.2. Market Value Forecast, By Region

5.2.2.2. Cloud Based Delivery

5.2.2.2.1. Absolute $ Opportunity

5.2.2.2.2. Market Value Forecast, By Region

5.2.2.3. Digital Pathology Information System

5.2.2.3.1. On-Premises Delivery

5.2.2.3.1.1. Absolute $ Opportunity

5.2.2.3.1.2. Market Value Forecast, By Region

5.2.2.3.2. Cloud Based Delivery

5.2.2.3.2.1. Absolute $ Opportunity

5.2.2.3.2.2. Market Value Forecast, By Region

5.2.3. Services

5.2.3.1. Installation and Integration

5.2.3.1.1. Absolute $ Opportunity

5.2.3.1.2. Market Value Forecast, By Region

5.2.3.2. Maintenance Services

5.2.3.2.1. Absolute $ Opportunity

5.2.3.2.2. Market Value Forecast, By Region

5.2.3.3. Consulting Services

5.2.3.3.1. Absolute $ Opportunity

5.2.3.3.2. Market Value Forecast, By Region

5.2.4. Market Attractiveness Analysis, By Product

6. Global Digital Pathology Market Analysis, By End Users

6.1. Introduction

6.1.1. Global Digital Pathology Market Snapshot By End User

6.1.2. Primary Outlook On the End User Segment

6.1.3. Y-o-Y Growth Comparison, By End Users

6.1.4. Basis Point Share (BPS) Analysis, By End Users

6.2. Market Forecast By End Users

6.2.1. Hospitals

6.2.1.1. Absolute $ Opportunity

6.2.1.2. Market Value Forecast, By Region

6.2.2. Diagnostic Labs

6.2.2.1. Absolute $ Opportunity

6.2.2.2. Market Value Forecast, By Region

6.2.3. Research Centers

6.2.3.1. Absolute $ Opportunity

6.2.3.2. Market Value Forecast, By Region

6.3. Market Attractiveness Analysis, By End Users

7. Global Digital Pathology Market Analysis, By Pathology Screening Services

7.1. Introduction

7.1.1. Global Digital Pathology Market Snapshot By Pathology Screening Services

7.1.2. Y-o-Y Growth Comparison, By Pathology Screening Services

7.1.3. Basis Point Share (BPS) Analysis, By Pathology Screening Services

7.1.4. Market Attractiveness Analysis, By Pathology Screening Services

7.2. Pricing Analysis: Digital Pathology Screening Services

7.3. Market Forecast By Pathology Screening Services

7.3.1. Chemical Pathology

7.3.1.1. Absolute $ Opportunity

7.3.1.2. Market Value Forecast, By Region

7.3.2. Haematology

7.3.2.1. Absolute $ Opportunity

7.3.2.2. Market Value Forecast, By Region

7.3.3. Histopathology

7.3.3.1. Absolute $ Opportunity

7.3.3.2. Market Value Forecast, By Region

7.3.4. Medical Microbiology

7.3.4.1. Absolute $ Opportunity

7.3.4.2. Market Value Forecast, By Region

8. Global Digital Pathology Market Analysis, By Region

8.1. Introduction

8.1.1. Y-o-Y Growth Projections, By Region

8.1.2. Basis Point Share (BPS) Analysis, By Region

8.2. Market Forecast By Region

8.2.1. North America Market Value Forecast

8.2.2. Latin America Market Value Forecast

8.2.3. Asia Pacific Excl. Japan Market Value Forecast

8.2.4. Western Europe Market Value Forecast

8.2.5. Eastern Europe Market Value Forecast

8.2.6. Middle East & Africa Market Value Forecast

8.2.7. Japan Market Value Forecast

8.3. Regional Attractiveness Analysis

9. North America Digital Pathology Market Analysis

9.1. Introduction

9.1.1. Y-o-Y Growth Projections, By Country

9.1.2. Basis Point Share (BPS) Analysis, By Country

9.1.3. Key Trends

9.2. North America Digital Pathology Market Forecast

9.2.1. Market Value Forecast By Country

9.2.1.1. U.S. Absolute $ Opportunity

9.2.1.2. Canada Absolute $ Opportunity

9.2.2. Market Value Forecast By Product

9.2.2.1. Scanners

9.2.2.1.1. Whole Slide Imaging System

9.2.2.1.1.1. Bright Field Scanner

9.2.2.1.1.2. Fluorescence Scanner

9.2.2.2. Software

9.2.2.2.1. Image Analysis Platform

9.2.2.2.1.1. On-Premises Delivery

9.2.2.2.1.2. Cloud Based Delivery

9.2.2.2.2. Digital Pathology Information System

9.2.2.2.2.1. On-Premises Delivery

9.2.2.2.2.2. Cloud Based Delivery

9.2.2.3. Services

9.2.2.3.1. Installation and Integration

9.2.2.3.2. Maintenance Services

9.2.2.3.3. Consulting Services

9.2.3. Market Value Forecast By End Users

9.2.3.1. Hospitals

9.2.3.1.1. 500+ Beds

9.2.3.1.2. 200-499 Beds

9.2.3.1.3. Less than 200 Beds

9.2.3.2. Diagnostic labs

9.2.3.2.1. Private Laboratories

9.2.3.2.2. Public Laboratories

9.2.3.3. Research Centers

9.2.4. Market Value Forecast By Pathology Screening Services

9.2.4.1. Hematology

9.2.4.2. Chemical Pathology

9.2.4.3. Histopathology

9.2.4.4. Medical Microbiology

9.2.5. Market Attractiveness Analysis

9.2.5.1. By Country

9.2.5.2. By Product

9.2.5.3. By Pathology Screening Services

9.2.5.4. By End Users

9.2.5.5. Drivers & Restraints: Impact Analysis

10. Latin America Digital Pathology Market Analysis

10.1. Introduction

10.1.1. Key Trends

10.1.2. Y-o-Y Growth Projections, By Country

10.1.3. Basis Point Share (BPS) Analysis, By Country

10.2. Latin America Digital Pathology Market Forecast

10.2.1. Market Value Forecast By Country

10.2.1.1. Mexico Absolute $ Opportunity

10.2.1.2. Brazil Absolute $ Opportunity

10.2.1.3. Rest of LATAM Absolute $ Opportunity

10.2.2. Market Value Forecast By Product

10.2.2.1. Scanners

10.2.2.1.1. Whole Slide Imaging System

10.2.2.1.1.1. Bright Field Scanner

10.2.2.1.1.2. Fluorescence Scanner

10.2.2.2. Software

10.2.2.2.1. Image Analysis Platform

10.2.2.2.1.1. On-Premises Delivery

10.2.2.2.1.2. Cloud Based Delivery

10.2.2.2.2. Digital Pathology Information System

10.2.2.2.2.1. On-Premises Delivery

10.2.2.2.2.2. Cloud Based Delivery

10.2.2.3. Services

10.2.2.3.1. Installation and Integration

10.2.2.3.2. Maintenance Services

10.2.2.3.3. Consulting Services

10.2.3. Market Value Forecast By End Users

10.2.3.1. Hospitals

10.2.3.1.1. 500+ Beds

10.2.3.1.2. 200-499 Beds

10.2.3.1.3. Less than 200 Beds

10.2.3.2. Diagnostic labs

10.2.3.2.1. Private Laboratories

10.2.3.2.2. Public Laboratories

10.2.3.3. Research Centers

10.2.4. Market Value Forecast By Pathology Screening Services

10.2.4.1. Hematology

10.2.4.2. Chemical Pathology

10.2.4.3. Histopathology

10.2.4.4. Medical Microbiology

10.2.5. Market Attractiveness Analysis

10.2.5.1. By Country

10.2.5.2. By Product

10.2.5.3. By Pathology Screening Services

10.2.5.4. By End Users

10.2.5.5. Drivers & Restraints: Impact Analysis

11. Western Europe Digital Pathology Market Analysis

11.1. Introduction

11.1.1. Y-o-Y Growth Projections, By Country / Region

11.1.2. Basis Point Share (BPS) Analysis, By Country / Region

11.1.3. Key Regulations

11.1.4. Key Trends

11.2. Western Europe Market Forecast

11.2.1. Market Value Forecast By Country/Region

11.2.1.1. Germany Absolute $ Opportunity

11.2.1.2. France Absolute $ Opportunity

11.2.1.3. U.K. Absolute $ Opportunity

11.2.1.4. Spain Absolute $ Opportunity

11.2.1.5. Italy Absolute $ Opportunity

11.2.1.6. Nordic Absolute $ Opportunity

11.2.1.7. BENELUX Absolute $ Opportunity

11.2.1.8. Rest of Western Europe Absolute $ Opportunity

11.2.2. Market Value Forecast By Product

11.2.2.1. Scanners

11.2.2.1.1. Whole Slide Imaging System

11.2.2.1.1.1. Bright Field Scanner

11.2.2.1.1.2. Fluorescence Scanner

11.2.2.2. Software

11.2.2.2.1. Image Analysis Platform

11.2.2.2.1.1. On-Premises Delivery

11.2.2.2.1.2. Cloud Based Delivery

11.2.2.2.2. Digital Pathology Information System

11.2.2.2.2.1. On-Premises Delivery

11.2.2.2.2.2. Cloud Based Delivery

11.2.2.3. Services

11.2.2.3.1. Installation and Integration

11.2.2.3.2. Maintenance Services

11.2.2.3.3. Consulting Services

11.2.3. Market Value Forecast By End Users

11.2.3.1. Hospitals

11.2.3.1.1. 500+ Beds

11.2.3.1.2. 200-499 Beds

11.2.3.1.3. Less than 200 Beds

11.2.3.2. Diagnostic labs

11.2.3.2.1. Private Laboratories

11.2.3.2.2. Public Laboratories

11.2.3.3. Research Centers

11.2.4. Market Value Forecast By Pathology Screening Services

11.2.4.1. Hematology

11.2.4.2. Chemical Pathology

11.2.4.3. Histopathology

11.2.4.4. Medical Microbiology

11.2.5. Market Attractiveness Analysis

11.2.5.1. By Country

11.2.5.2. By Product

11.2.5.3. By Pathology Screening Services

11.2.5.4. By End Users

11.2.5.5. Drivers & Restraints: Impact Analysis

12. Eastern Europe Digital Pathology Market Analysis

12.1. Introduction

12.1.1. Y-o-Y Growth Projections, By Country / Region

12.1.2. Basis Point Share (BPS) Analysis, By Country / Region

12.1.3. Key Regulations

12.1.4. Key Trends

12.2. Eastern Europe Market Forecast

12.2.1. Market Value Forecast By Country/Region

12.2.1.1. Russia Absolute $ Opportunity

12.2.1.2. Poland Absolute $ Opportunity

12.2.1.3. Rest of Eastern Europe Absolute $ Opportunity

12.2.2. Market Value Forecast By Product

12.2.2.1. Scanners

12.2.2.1.1. Whole Slide Imaging System

12.2.2.1.1.1. Bright Field Scanner

12.2.2.1.1.2. Fluorescence Scanner

12.2.2.2. Software

12.2.2.2.1. Image Analysis Platform

12.2.2.2.1.1. On-Premises Delivery

12.2.2.2.1.2. Cloud Based Delivery

12.2.2.2.2. Digital Pathology Information System

12.2.2.2.2.1. On-Premises Delivery

12.2.2.2.2.2. Cloud Based Delivery

12.2.2.3. Services

12.2.2.3.1. Installation and Integration

12.2.2.3.2. Maintenance Services

12.2.2.3.3. Consulting Services

12.2.3. Market Value Forecast By End Users

12.2.3.1. Hospitals

12.2.3.1.1. 500+ Beds

12.2.3.1.2. 200-499 Beds

12.2.3.1.3. Less than 200 Beds

12.2.3.2. Diagnostic labs

12.2.3.2.1. Private Laboratories

12.2.3.2.2. Public Laboratories

12.2.3.3. Research Centers

12.2.4. Market Value Forecast By Pathology Screening Services

12.2.4.1. Hematology

12.2.4.2. Chemical Pathology

12.2.4.3. Histopathology

12.2.4.4. Medical Microbiology

12.2.5. Market Attractiveness Analysis

12.2.5.1. By Country

12.2.5.2. By Product

12.2.5.3. By Pathology Screening Services

12.2.5.4. By End Users

12.2.5.5. Drivers & Restraints: Impact Analysis

13. APEJ Digital Pathology Market Analysis

13.1. Introduction

13.1.1. Y-o-Y Growth Projections, By Country

13.1.2. Basis Point Share (BPS) Analysis, By Country / Region

13.1.3. Key Regulations

13.1.4. Key Trends

13.2. APEJ Market Forecast

13.2.1. Market Value Forecast By Country/Region

13.2.1.1. China Absolute $ Opportunity

13.2.1.2. India Absolute $ Opportunity

13.2.1.3. ASEAN Absolute $ Opportunity

13.2.1.4. ANZ Absolute $ Opportunity

13.2.1.5. Rest of APEJ Absolute $ Opportunity

13.2.2. Market Value Forecast By Product

13.2.2.1. Scanners

13.2.2.1.1. Whole Slide Imaging System

13.2.2.1.1.1. Bright Field Scanner

13.2.2.1.1.2. Fluorescence Scanner

13.2.2.2. Software

13.2.2.2.1. Image Analysis Platform

13.2.2.2.1.1. On-Premises Delivery

13.2.2.2.1.2. Cloud Based Delivery

13.2.2.2.2. Digital Pathology Information System

13.2.2.2.2.1. On-Premises Delivery

13.2.2.2.2.2. Cloud Based Delivery

13.2.2.3. Services

13.2.2.3.1. Installation and Integration

13.2.2.3.2. Maintenance Services

13.2.2.3.3. Consulting Services

13.2.3. Market Value Forecast By End Users

13.2.3.1. Hospitals

13.2.3.1.1. 500+ Beds

13.2.3.1.2. 200-499 Beds

13.2.3.1.3. Less than 200 Beds

13.2.3.2. Diagnostic labs

13.2.3.2.1. Private Laboratories

13.2.3.2.2. Public Laboratories

13.2.3.3. Research Centers

13.2.4. Market Value Forecast By Pathology Screening Services

13.2.4.1. Hematology

13.2.4.2. Chemical Pathology

13.2.4.3. Histopathology

13.2.4.4. Medical Microbiology

13.2.5. Market Attractiveness Analysis

13.2.5.1. By Country

13.2.5.2. By Product

13.2.5.3. By Pathology Screening Services

13.2.5.4. By End Users

13.2.5.5. Drivers & Restraints: Impact Analysis

14. Japan Digital Pathology Market Analysis

14.1. Introduction

14.1.1. Y-o-Y Growth Projections, By Country / Region

14.1.2. Key Regulations

14.1.3. Key Trends

14.2. Japan Market Forecast

14.2.1. Market Value Forecast By Product

14.2.1.1. Scanners

14.2.1.1.1. Whole Slide Imaging System

14.2.1.1.1.1. Bright Field Scanner

14.2.1.1.1.2. Fluorescence Scanner

14.2.1.2. Software

14.2.1.2.1. Image Analysis Platform

14.2.1.2.1.1. On-Premises Delivery

14.2.1.2.1.2. Cloud Based Delivery

14.2.1.2.2. Digital Pathology Information System

14.2.1.2.2.1. On-Premises Delivery

14.2.1.2.2.2. Cloud Based Delivery

14.2.1.3. Services

14.2.1.3.1. Installation and Integration

14.2.1.3.2. Maintenance Services

14.2.1.3.3. Consulting Services

14.2.2. Market Value Forecast By End Users

14.2.2.1. Hospitals

14.2.2.1.1. 500+ Beds

14.2.2.1.2. 200-499 Beds

14.2.2.1.3. Less than 200 Beds

14.2.2.2. Diagnostic labs

14.2.2.2.1. Private Laboratories

14.2.2.2.2. Public Laboratories

14.2.2.3. Research Centers

14.2.3. Market Value Forecast By Pathology Screening Services

14.2.3.1. Hematology

14.2.3.2. Chemical Pathology

14.2.3.3. Histopathology

14.2.3.4. Medical Microbiology

14.2.4. Market Attractiveness Analysis

14.2.4.1. By Country

14.2.4.2. By Product

14.2.4.3. By Pathology Screening Services

14.2.4.4. By End Users

14.2.4.5. Drivers & Restraints: Impact Analysis

15. Middle East & Africa Digital Pathology Market Analysis

15.1. Introduction

15.1.1. Y-o-Y Growth Projections, By Country / Region

15.1.2. Basis Point Share (BPS) Analysis, By Country / Region

15.1.3. Key Regulations

15.1.4. Key Trends

15.2. Middle East & Africa Market Forecast

15.2.1. Market Value Forecast By Country/Region

15.2.1.1. GCC Absolute $ Opportunity

15.2.1.2. N. Africa Absolute $ Opportunity

15.2.1.3. S. Africa Absolute $ Opportunity

15.2.1.4. Rest of MEA Absolute $ Opportunity

15.2.2. Market Value Forecast By Product

15.2.2.1. Scanners

15.2.2.1.1. Whole Slide Imaging System

15.2.2.1.1.1. Bright Field Scanner

15.2.2.1.1.2. Fluorescence Scanner

15.2.2.2. Software

15.2.2.2.1. Image Analysis Platform

15.2.2.2.1.1. On-Premises Delivery

15.2.2.2.1.2. Cloud Based Delivery

15.2.2.2.2. Digital Pathology Information System

15.2.2.2.2.1. On-Premises Delivery

15.2.2.2.2.2. Cloud Based Delivery

15.2.2.3. Services

15.2.2.3.1. Installation and Integration

15.2.2.3.2. Maintenance Services

15.2.2.3.3. Consulting Services

15.2.3. Market Value Forecast By End Users

15.2.3.1. Hospitals

15.2.3.1.1. 500+ Beds

15.2.3.1.2. 200-499 Beds

15.2.3.1.3. Less than 200 Beds

15.2.3.2. Diagnostic labs

15.2.3.2.1. Private Laboratories

15.2.3.2.2. Public Laboratories

15.2.3.3. Research Centers

15.2.4. Market Value Forecast By Pathology Screening Services

15.2.4.1. Hematology

15.2.4.2. Chemical Pathology

15.2.4.3. Histopathology

15.2.4.4. Medical Microbiology

15.2.5. Market Attractiveness Analysis

15.2.5.1. By Country

15.2.5.2. By Product

15.2.5.3. By Pathology Screening Services

15.2.5.4. By End Users

15.2.5.5. Drivers & Restraints: Impact Analysis

16. Competition Landscape

16.1. Competition Dashboard

16.2. Company Profiles

16.2.1. Perkin Elmer, Inc.

16.2.2. Definiens AG

16.2.3. Sectra ABss

16.2.4. Koninklijke Philips N.V

16.2.5. GE Healthcare

16.2.6. Inspirata Co.

16.2.7. Ventana Medical Systems, Inc.

16.2.8. Leica Biosystems

16.2.9. 3D-Histech Ltd

16.2.10. Hamamatsu Photonics, K.K.

16.2.11. Digipath Co.

16.2.12. ZEISS

16.2.13. Olympus Corporation

16.2.14. Yokogawa Electronic Corporation

16.2.15. Quorum Technologies Inc.



【レポートのキーワード】

デジタルパソロジー

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[デジタルパソロジーの世界市場:産業分析・機会分析]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月08日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆